Anagnostics Boosts Sales Force
News Feb 05, 2013
Karl Winkler (48) is another sales professional checking in at Anagnostics Bioanalysis GmbH (St. Valentin/NÖ).
Karl holds a sales diploma and worked for Heinen & Loewenstein - a medtech company - and for Messer Medical Austria.
In both positions he was responsible for the build-up of sales infrastructure and sales in Austria and abroad.
Karl Winkler worked already 20 years in sales and sales management, 11 years thereof in the medical field.
Karl’s field of excellence is drugs of abuse analytics. For the beginning he will focus on sales of drugs of abuse screening tests in German speaking countries (Germany, Austria, Switzerland).
Karl Winkler: “Anagnostics is a dynamic enterprise, which is now in the phase of market expansion. Our proprietary hybcell technology promises huge market potential and I am eager to contribute to the success of the company.”
Anagnostics Bioanalysis offers its innovative multiplexed diagnostics technology named hybcell technology in three areas: drugs of abuse screening for drug therapy, in the field of personalized medicine (companion diagnostics) and for integrated sepsis diagnostics.
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria with antibiotics, researchers treated infected mice with molecules that block toxin formation in bacteria.READ MORE
8th Edition of International Conference and Exhibition on Separation Techniques
Jul 29 - Jul 30, 2019